Among the companies with shares expected to actively trade in
Friday's session are Priceline.com Inc. (PCLN), Monster Beverage
Corp. (MNST) and Rackspace Hosting Inc. (RAX).
Priceline's second-quarter earnings increased 24% as the
online-travel agent recorded stronger margins and continued
international bookings growth. Shares were up 5.5% at $985 after
hours as results topped the company's expectations.
Monster Beverage's second-quarter earnings fell 2.7% amid
expenses related to litigation and regulatory issues regarding
alleged health risks posed by energy drinks. Shares were down 4.3%
at $60.75 in after-hours trading as revenue growth fell into the
single digits on a percentage basis and also missed analysts'
expectations.
Rackspace's second-quarter profit slid 11% as marketing,
research and other costs jumped, masking a double-digit increase in
the data-center provider's sales. Still, shares jumped 11% to $49
in after-hours trading, as the results exceeded Wall Street
expectations.
Allscripts Healthcare Solutions Inc. (MDRX) swung to a
second-quarter loss amid acquisition- and restructuring-related
charges and other items as the electronic health-records company
also recorded weaker revenue. Shares were down 6.4% at $15.10 in
after-hours trading as adjusted earnings and revenue missed
analysts' expectations.
Brooks Automation Inc.'s (BRKS) fiscal third-quarter profit
plunged 81% as the technology-products company posted lower revenue
and income from joint ventures. Shares were down 13% to $8.50 after
hours as the company issued weaker-than-expected guidance for the
current quarter.
Dendreon Corp.'s (DNDN) second-quarter loss narrowed as the
pharmaceutical company cut operating expenses, though revenue
continued to decline. Results were weaker than analysts had
expected, and the company said that based on current enrollment
trends in July and August, it doesn't expect enough of a sales
increase in the second half of the year to meet its goal of
increasing sales of its prostate-cancer drug Provenge
year-over-year. Shares slumped 13% to $3.98 after hours.
Molycorp Inc.'s (MCP) second-quarter loss widened on higher
costs and as prior-year results benefited from a higher income-tax
benefit, though the rare-earth mining company's revenue jumped due
to rising volume. Results for Molycorp, which manufacturers and
sells rare-earth products used in high-tech gadgets, missed Wall
Street expectations. Shares were down 14% to $6.41 after hours.
Chinese money manager Noah Holdings Ltd. (NOAH) lifted its
full-year earnings outlook, saying business has grown faster than
expected. Noah's American depositary shares jumped 15% to $15 in
after-hours trading.
Tableau Software (DATA) swung to a second-quarter loss as the
data-analysis software maker posted higher costs that masked a
double-digit revenue gain. Still, shares of the company were up 13%
to $69 after hours as the results beat analysts' expectations.
Ubiquiti Networks Inc.'s (UBNT) fiscal fourth-quarter profit
rose 1.3% as the company said it was gaining traction in the
discount networking market. Shares surged 25% to $26.50 after-hours
Thursday as results easily surpassed the company's own estimates
and it offered a rosy view of the fiscal first quarter.
Universal Display Corp.'s (OLED) shares jumped in after-hours
trading Thursday, after the light and electronics flat-panel
display developer reported a 40% jump in second-quarter profit,
topping Wall Street expectations. Sales growth was also impressive,
led by strong demand for materials. Shares climbed 21% to $35.60
after hours.
The U.S. Food and Drug Administration doesn't believe it can
approve Wright Medical Group Inc.'s (WMGI) bioengineered bone graft
for foot and ankle fusion surgery, noting problems with the
clinical study, the company said. Shares fell 11% to $24.10 in
after-hours trading.
Watchlist:
Assured Guaranty Ltd.'s (AGO) second-quarter earnings fell 42%
as the bond insurer reported a lower fair-value gain and a decrease
in net earned premiums.
CareFusion Corp.'s (CFN) fiscal fourth-quarter earnings
increased 14% as the medical-equipment company's margins improved
and overhead expenses decreased, though medial-systems sales
weakened.
DeVry Inc. (DV) swung to a fiscal fourth-quarter loss as the
for-profit education company again posted weaker enrollment, along
with higher restructuring expenses and write-downs.
Dish Network Corp. (DISH) called on Congress to update local TV
carriage rules, saying outdated retransmission rules have resulted
in a historic number of blackouts.
Gap Inc. (GPS) projected fiscal second-quarter earnings ahead of
Wall Street's estimates, while also reporting same-store sales for
July that were slightly weaker-than-expected.
Gleacher & Co.'s (GLCH) second-quarter loss widened as the
boutique firm incurred a restructuring charge related to its exits
from its investment-banking and fixed-income businesses.
Great Plains Energy Inc.'s (GXP) second-quarter profit rose 9.5%
as the utility was buoyed by a positive effect from rates that
masked a slight decline in revenue.
J.C. Penney Co. (JCP) Chairman Thomas Engibous affirmed his
support for Chief Executive Myron Ullman, saying Mr. Ullman has led
"significant actions to correct the errors of previous management"
since he retook the helm of the struggling department-store
retailer four months ago.
Lions Gate Entertainment Corp. (LGF) swung to a fiscal
first-quarter profit as fans continued to watch the last of the
"Twilight" series and other Lions Gate movies and TV shows from the
comfort of their sofas.
Expenses tied to Noodles & Co.'s (NDLS) initial public
offering weighed on the fast-casual dining chain's second-quarter
profit, though the company's first results since debuting on the
market exceeded Wall Street's expectations.
Activist investor Carl Icahn has bought more shares of
speech-recognition technology maker Nuance Communications Inc.
(NUAN), lifting his stake to 16%.
Nvidia Corp.'s (NVDA) fiscal second-quarter profit fell 19% as
the chip maker's revenue fell.
Onyx Pharmaceuticals Inc.'s (ONXX) second-quarter loss narrowed
as the cancer-drug maker's sales more than doubled from a year ago,
helping results modestly exceed Wall Street expectations.
Stifel Financial Corp.'s (SF) second-quarter earnings rose 13%
as the regional broker posted stronger revenue, led by strong
growth in its investment-banking business.
Drug developer Synergy Pharmaceuticals Inc. (SGYP) plans to spin
off the part of its business working on a shingles treatment as a
separate publicly traded company.
Write to Nathalie Tadena at nathalie.tadena@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires